Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Tailored care plan shows promise for frail seniors

NCT ID NCT07623694

Disease control Sponsor: Pirogov Russian National Research Medical University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a personalized management program for 115 older adults with frailty. The program includes exercise, nutrition advice, and medical adjustments, starting with a short hospital stay and continuing at home for 6 months. Researchers measure changes in daily function and exercise capacity to see if the program helps.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
personalized geriatric rehabilitation program
What this could lead to
If successful, this could point toward an effective way to help older adults with frailty stay independent and improve their physical fitness.
What could go wrong
This is a small, early-stage study with no control group, so results may not be widely applicable. The program is intensive and may be hard for some to follow long-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 115 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2026

Expected to finish

Apr 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

60 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1\. Men and women aged 60 and older who wanted to participate in the study and signed a consent form. Exclusion Criteria: 1. Presence of acute diseases or exacerbation of chronic diseases within 2 weeks prior to study inclusion. 2. Presence of active malignant oncological diseases. 3. Presence of severe cognitive impairment (dementia) and sensory deficits that may affect the ability to perform or evaluate study procedures. 4. Presence of anemia (hemoglobin level \<110 g/L). 5. Presence of musculoskeletal disorders or peripheral artery disease that may affect mobility and the ability to undergo study procedures. 6. Presence of one or more contraindications to exercise testing. 7. Any other condition that, in the investigator's opinion, may preclude the patient's participation in the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Frailty are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Frailty Sarcopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Frailty Frailty/sarcopenia

Contacts and locations

Locations

  • Russian Research and Clinical Center for Gerontology

    Moscow, 129226, Russia

More trials for these conditions

Other studies related to the condition(s) this trial covers.